Pearson Lab Overcoming the complexity of cancer
Lab News
2024
September 2024
It's the end of the summer, which means it's time to say see you later to our three amazing summer students, Louis, Lexie and Bea. It's been great to have them in the lab, and crazy to see how fast time flies - Bea was with us for 16 months! But we also get to welcome our first two Grad Students, Pinky Sharma and Reshani Perera, as well as welcoming back Diya Ukani as an Undergraduate Research Assistant in the lab.
Welcome Pinky, Reshani & Diya!!
July 2024
This month we were honored to have Christine Wu and her lung cancer patient group visit our lab and hear about our research. It was a very inspiring and eye opening experience for us in the lab. We're really looking forward to continue to build this relationship and partner with Christine and others from the group in our research. See Christine's YouTube channel for a nice summary of the visit: Episode 42: Visiting a Cancer Research Lab in My City (youtube.com)
June 2024
We're excited to share that we received an NSERC Discovery Grant to support our work on developing improved CRISPR gene editing techniques. Thanks to the reviewers and NSERC for supporting this exciting work!
May 2024
We're excited to have Louis Dela Pena back for another summer in the lab, and he will be joined by Lexie Desjarlais.
Welcome Lexie and welcome back Louis!!
February 2024
The good funding news this year keeps coming. We just received a 5 year CIHR project grant to explore epigenetic and transcriptional mechanisms that drive small cell lung cancer evolution and drug resistance and to identify novel strategies to therapeutically target the unique epigenetic landscape of small cell lung cancer. Thanks CIHR for support our research!
January 2024
We had a great start to the year and just got our first national grant! We received a 5 year Emerging Scholar Research Grant from the Canadian Cancer Society to better understand the mechanisms underlying the genesis and progression of small cell lung cancer. Thanks CCS for supporting our research!
2023
November 2023
We're so excited to see the lab continue to grow with Nivitha Bhaskar and Liat Stitz who have joined as Research Assistants.
Welcome Nivitha & Liat!!
September 2023
It was bitter sweet saying good bye to my first student. Louis had a great 8 months in the lab and accomplished a ton in that time. Thanks Louis! But I am excited that Diya and Bea are sticking around for a little while longer to keep up all their hard work in the lab. I also remembered to get a picture at our good bye lunch for Louis so I now have proof that my lab exists.
August 2023
I had a great time at the SCLC Young Investigators Forum Aug 1-3 in New Orleans. It was a great privilege to be selected to speak about our work on YAP/TEAD in SCLC at this fantastic meeting and to meet everyone involved. It was also really exciting to win the 2nd runner up prize at this highly-competitive meeting. Thanks to the organizers and sponsors!
August 2023
We received funding from the CancerCare Manitoba Foundation to support our work on the YAP/TEAD pathway in small cell neuroendocrine cancers. Thanks CCMF for your support!!
May 2023
We're really happy to have Diya Ukani join the lab as a summer co-op student and Bea Ricarte join as a Honors student. The benches are starting to get full now!
Welcome Diya & Bea!!
January 2023
The Pearson lab is excited to welcome our first ever student, Louis Dela Pena. Louis is joining us as a co-op student for the next few months working on the YAP-TEAD pathway in small cell lung cancer.
Welcome Louis!!
2022
November 2022
We were recently interviewed by The Scientist regarding our COVID-19 and cancer work and the experience switching from studying cancer to COVID-19 during the pandemic. The interview is now online and you can read it here.
September 2022
The Pearson lab is officially up and running (sort of) at the CancerCare Manitoba Research Institute! We're recruiting undergraduates, grad students and postdocs interested in better understanding the molecular basis of cancer and identifying new cancer therapeutics.